1. Home
  2. DMRC vs STXS Comparison

DMRC vs STXS Comparison

Compare DMRC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$9.48

Market Cap

170.6M

Sector

Technology

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.88

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRC
STXS
Founded
2008
1990
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.6M
190.6M
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
DMRC
STXS
Price
$9.48
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$4.00
AVG Volume (30 Days)
276.6K
345.6K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
18.58
16.67
EPS
N/A
N/A
Revenue
$25,213,000.00
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
15.69
N/A
52 Week Low
$4.07
$1.70
52 Week High
$17.47
$3.59

Technical Indicators

Market Signals
Indicator
DMRC
STXS
Relative Strength Index (RSI) 38.41 50.95
Support Level $9.52 $1.74
Resistance Level $10.31 $1.99
Average True Range (ATR) 1.26 0.09
MACD -0.68 -0.00
Stochastic Oscillator 3.78 52.00

Price Performance

Historical Comparison
DMRC
STXS

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: